Deep Brain Stimulation (DBS) is an FDA-approved procedure, a two-part surgery that involves implanting a device that sends ...

The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...

Results from a Phase III registrational study suggest that ecopipam has potential as a first-in-class dopamine-1 receptor ...

The next episode of “Baylen Out Loud” is called “You Don’t Have to Stare Into My Soul.” “Baylen Out Loud” airs at 9 p.m.

Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...

In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...

Emalex Biosciences met primary and secondary endpoints in its Phase 3 registrational trial of ecopipam for patients with ...

Colin asks Baylen's parents for their approval so he can propose to her in a new episode of "Baylen Out Loud," airing on ...

Wake Forest University School of Medicine and Atrium Health Wake Forest Baptist Medical Center have been recognized by the ...

“Baylen Out Loud” continues with Season 1, Episode 8, “You Don’t Have to Stare Into My Soul,” airing Monday, March 3 ...